v3.19.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue
Operating expenses:        
Research and development 784,331 1,394,177 1,229,733 2,086,902
Sales and marketing 46,663 56,050 103,679 68,550
Depreciation and amortization 43,045 29,732 72,748 60,293
General and administrative 2,101,287 834,172 3,955,971 1,283,201
Total operating expenses 2,975,326 2,314,131 5,362,131 3,498,946
Loss from operations (2,975,326) (2,314,131) (5,362,131) (3,498,946)
Other (expense) income:        
Interest expense (252,627) (822,858) (419,514)
Interest income 1,792 1,669 3,110 1,706
Total other (expense) income 1,792 (250,958) (819,748) (417,808)
Loss before income taxes (2,973,534) (2,565,089) (6,181,879) (3,916,754)
Income tax (expense) benefit
Net loss (2,973,534) (2,565,089) (6,181,879) (3,916,754)
Dividend to series A and B preferred stockholders (320,000) (160,219) (640,000)
Net loss attributable to common stockholders $ (2,973,534) $ (2,885,089) $ (6,342,098) $ (4,556,754)
Net loss per common share, basic and diluted (in dollars per share) $ (0.20) $ (1.56) $ (0.56) $ (2.49)
Weighted average number of common shares outstanding, basic and diluted (in shares) 14,801,116 1,845,254 11,292,738 1,832,905

Source